Clinical Risk Factors for Malignancy in Pheochromocytomas and Paragangliomas

被引：0
|
作者：
Ayala-Ramirez, M. [1 ]
Hernandez, M. [1 ]
Habra, M. A. [1 ]
Busaidy, N. L. [1 ]
Cote, G. [1 ]
Rich, T. A. [1 ]
Waguespack, S. [1 ]
Jimenez, C. [1 ]
机构：
[1] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
ENDOCRINE REVIEWS | 2010年 / 31卷 / 03期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：S840 / S840
页数：1
相关论文
共 50 条
  • [1] Disentangling of Malignancy from Benign Pheochromocytomas/Paragangliomas
    Kim, Kyong Young
    Kim, Jung Hee
    Hong, A. Ram
    Seong, Moon-Woo
    Lee, Kyu Eun
    Kim, Su-Jin
    Kim, Sang Wan
    Shin, Chan Soo
    Kim, Seong Yeon
    PLOS ONE, 2016, 11 (12):
  • [2] CLINICAL ASPECTS OF PHEOCHROMOCYTOMAS AND PARAGANGLIOMAS IN CHILDREN: HIGH FREQUENCY OF GERMLINE MUTATIONS AND MALIGNANCY
    van der Sluis, Inge
    Boerman, Harmke
    Gaal, Jose
    Links, Thera
    de Krijger, Ronald
    van Noesel, Max
    PEDIATRIC BLOOD & CANCER, 2010, 55 (05) : 910 - 911
  • [3] Clinical Risk Factors for Malignancy and Overall Survival in Patients with Pheochromocytomas and Sympathetic Paragangliomas: Primary Tumor Size and Primary Tumor Location as Prognostic Indicators
    Ayala-Ramirez, Montserrat
    Feng, Lei
    Johnson, Marcella M.
    Ejaz, Shamim
    Habra, Mouhammed Amir
    Rich, Thereasa
    Busaidy, Naifa
    Cote, Gilbert J.
    Perrier, Nancy
    Phan, Alexandria
    Patel, Shreyaskumar
    Waguespack, Steven
    Jimenez, Camilo
    JOURNAL OF CLINICAL ENDOCRINOLOGY & METABOLISM, 2011, 96 (03): : 717 - 725
  • [4] Pheochromocytomas and paragangliomas: clinical and genetic approaches
    Soares Costa, Marcia Helena
    Ortiga-Carvalho, Tania M.
    Violante, Alice Dutra
    Vaisman, Mario
    FRONTIERS IN ENDOCRINOLOGY, 2015, 6
  • [5] Diversity of pheochromocytomas/paragangliomas in clinical practice
    Yamashita, Yui
    Kanai, Yugo
    Yonemitsu, Shin
    Masatsugu, Ken
    Muro, Seiji
    Oki, Shogo
    ENDOCRINE JOURNAL, 2010, 57 : S632 - S633
  • [6] SDHB: A Marker of Malignancy in Familial and Sporadic Pheochromocytomas/Sympathethic Paragangliomas
    Blank, A.
    Schmitt, A. M.
    Korpershoek, E.
    van Nederveen, F. H.
    Rudolph, T.
    Weber, N.
    Strebel, R.
    de Krijger, R.
    Komminoth, P.
    Perren, A.
    MODERN PATHOLOGY, 2011, 24 : 134A - 134A
  • [7] SDHB: A Marker of Malignancy in Familial and Sporadic Pheochromocytomas/Sympathethic Paragangliomas
    Blank, A.
    Schmitt, A. M.
    Korpershoek, E.
    van Nederveen, F. H.
    Rudolph, T.
    Weber, N.
    Strebel, R.
    de Krijger, R.
    Komminoth, P.
    Perren, A.
    LABORATORY INVESTIGATION, 2011, 91 : 134A - 134A
  • [8] Predictors of malignancy in patients with pheochromocytomas/paragangliomas: Asian Indian experience
    Khadilkar, Kranti
    Sarathi, Vijaya
    Kasaliwal, Rajeev
    Pandit, Reshma
    Goroshi, Manjunath
    Malhotra, Gaurav
    Dalvi, Abhay
    Bakshi, Ganesh
    Bhansali, Anil
    Rajput, Rajesh
    Shivane, Vyankatesh
    Lila, Anurag
    Bandgar, Tushar
    Shah, Nalini S.
    ENDOCRINE CONNECTIONS, 2016, 5 (06): : 89 - 97
  • [9] Pheochromocytomas and Paragangliomas
    Tevosian, Sergei G.
    Ghayee, Hans K.
    ENDOCRINOLOGY AND METABOLISM CLINICS OF NORTH AMERICA, 2019, 48 (04) : 727 - +
  • [10] Pheochromocytomas and paragangliomas
    Yen, Kevin
    Lodish, Maya
    CURRENT OPINION IN PEDIATRICS, 2021, 33 (04) : 430 - 435
12345